0 results:

• Genesys Capital is closing its largest fund to date – Genesys Ventures IV LP
  Genesys Capital (“Genesys”) is pleased to announce the upcoming closing of Genesys Ventures IV LP (“Fund IV” or the “fund”) to continue its successful track record of building Canadian life science companies in both the medtech and biotech sectors.https://www.businesswire.com/news/home/20250611527967/en/Genesys-Capital-is-Closing-its-Largest-Fund-to-Date-Genesys-Ventures-IV-LP?utm_campaign=shareaholic&utm_medium=copy_link&utm_source=bookmark
• HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors
  HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced a management-led majority stake acquisition by a syndicate of globally recognized private and public investors, including K5 Global, Bezos Expeditions, Wellington Management and other new and existing investors. https://www.businesswire.com/news/home/20250807749442/en/HistoSonics-Announces-%242.25B-Acquisition-by-Consortium-of-Top-Tier-Investors